Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plasmodium berghei | 13 | 2016 | 29 | 3.530 |
Why?
|
| Malaria | 8 | 2016 | 68 | 2.040 |
Why?
|
| Glutathione | 4 | 2016 | 160 | 1.550 |
Why?
|
| Antimalarials | 11 | 2015 | 48 | 1.540 |
Why?
|
| Glutamate-Cysteine Ligase | 5 | 2016 | 17 | 1.370 |
Why?
|
| Protozoan Proteins | 9 | 2015 | 170 | 1.140 |
Why?
|
| Glutathione Reductase | 2 | 2016 | 22 | 0.950 |
Why?
|
| Chloroquine | 3 | 2015 | 19 | 0.930 |
Why?
|
| Drug Resistance, Multiple | 5 | 2009 | 26 | 0.800 |
Why?
|
| Artemisinins | 2 | 2015 | 17 | 0.780 |
Why?
|
| ATP-Binding Cassette Transporters | 4 | 2009 | 82 | 0.730 |
Why?
|
| Plasmodium falciparum | 9 | 2015 | 121 | 0.670 |
Why?
|
| Plasmodium yoelii | 3 | 2004 | 10 | 0.660 |
Why?
|
| Tropical Medicine | 1 | 2016 | 7 | 0.580 |
Why?
|
| Erythrocytes | 3 | 2011 | 107 | 0.530 |
Why?
|
| Drug Resistance | 2 | 2015 | 93 | 0.520 |
Why?
|
| Malaria, Falciparum | 4 | 2010 | 81 | 0.500 |
Why?
|
| Schools, Medical | 1 | 2016 | 192 | 0.490 |
Why?
|
| Oocysts | 2 | 2010 | 4 | 0.470 |
Why?
|
| Multidrug Resistance-Associated Proteins | 2 | 2015 | 42 | 0.470 |
Why?
|
| Public Health | 1 | 2016 | 348 | 0.430 |
Why?
|
| Parasitemia | 1 | 2011 | 13 | 0.410 |
Why?
|
| Staining and Labeling | 1 | 2011 | 100 | 0.400 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 173 | 0.380 |
Why?
|
| Animals | 22 | 2016 | 14307 | 0.370 |
Why?
|
| Flow Cytometry | 1 | 2011 | 392 | 0.370 |
Why?
|
| Mice | 15 | 2015 | 5668 | 0.370 |
Why?
|
| Polymerase Chain Reaction | 4 | 2009 | 430 | 0.310 |
Why?
|
| Computational Biology | 1 | 2009 | 275 | 0.290 |
Why?
|
| Molecular Sequence Data | 7 | 2011 | 1490 | 0.250 |
Why?
|
| Genes, MDR | 1 | 2004 | 2 | 0.250 |
Why?
|
| Sporozoites | 2 | 2015 | 6 | 0.230 |
Why?
|
| Amino Acid Sequence | 5 | 2009 | 1124 | 0.210 |
Why?
|
| Chromosome Mapping | 3 | 2009 | 159 | 0.180 |
Why?
|
| Indoles | 2 | 2011 | 154 | 0.180 |
Why?
|
| Fasciola hepatica | 3 | 1986 | 33 | 0.180 |
Why?
|
| Blotting, Southern | 3 | 2009 | 66 | 0.180 |
Why?
|
| Travel | 1 | 1999 | 32 | 0.170 |
Why?
|
| Mefloquine | 1 | 1999 | 3 | 0.170 |
Why?
|
| Genes, Protozoan | 1 | 1999 | 18 | 0.170 |
Why?
|
| Chromosomes | 1 | 1999 | 35 | 0.170 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 396 | 0.160 |
Why?
|
| Structure-Activity Relationship | 3 | 2014 | 376 | 0.160 |
Why?
|
| Female | 11 | 2015 | 19873 | 0.150 |
Why?
|
| DNA, Protozoan | 3 | 2002 | 21 | 0.150 |
Why?
|
| Open Reading Frames | 2 | 2009 | 73 | 0.150 |
Why?
|
| RNA, Protozoan | 2 | 2009 | 13 | 0.140 |
Why?
|
| Life Cycle Stages | 1 | 2016 | 27 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 46 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2016 | 110 | 0.140 |
Why?
|
| Thioredoxins | 1 | 2016 | 43 | 0.140 |
Why?
|
| DNA, Mitochondrial | 1 | 2016 | 165 | 0.130 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2014 | 65 | 0.130 |
Why?
|
| Blood | 3 | 2015 | 32 | 0.120 |
Why?
|
| Sequence Alignment | 2 | 2009 | 257 | 0.120 |
Why?
|
| Cell Nucleus | 1 | 2016 | 351 | 0.120 |
Why?
|
| Gene Expression | 2 | 2009 | 639 | 0.120 |
Why?
|
| DNA Damage | 1 | 2016 | 341 | 0.120 |
Why?
|
| Liver | 1 | 2015 | 447 | 0.110 |
Why?
|
| Schistosoma mansoni | 2 | 1983 | 20 | 0.110 |
Why?
|
| Antigens | 2 | 1983 | 56 | 0.110 |
Why?
|
| Antioxidants | 1 | 2016 | 386 | 0.110 |
Why?
|
| Thiazepines | 1 | 2011 | 4 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 605 | 0.110 |
Why?
|
| Electron Transport Complex III | 1 | 2011 | 12 | 0.110 |
Why?
|
| Bisbenzimidazole | 1 | 2011 | 2 | 0.100 |
Why?
|
| Propidium | 1 | 2011 | 18 | 0.100 |
Why?
|
| Rhodamines | 1 | 2011 | 20 | 0.100 |
Why?
|
| Ribonucleases | 1 | 2011 | 29 | 0.100 |
Why?
|
| Gene Dosage | 2 | 2004 | 74 | 0.100 |
Why?
|
| Limit of Detection | 1 | 2011 | 56 | 0.100 |
Why?
|
| Puerto Rico | 1 | 2016 | 1352 | 0.100 |
Why?
|
| Fluorescence | 1 | 2011 | 117 | 0.100 |
Why?
|
| Silanes | 1 | 2010 | 5 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 200 | 0.100 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2010 | 7 | 0.100 |
Why?
|
| Methylene Blue | 1 | 2010 | 5 | 0.100 |
Why?
|
| Glutathione Disulfide | 1 | 2010 | 7 | 0.100 |
Why?
|
| Eosine I Bluish | 1 | 2010 | 4 | 0.100 |
Why?
|
| Fluoresceins | 1 | 2010 | 27 | 0.100 |
Why?
|
| Amines | 1 | 2010 | 38 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2016 | 874 | 0.090 |
Why?
|
| Hepatocytes | 2 | 2015 | 74 | 0.090 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 2000 | 27 | 0.090 |
Why?
|
| Base Sequence | 3 | 2002 | 932 | 0.090 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 608 | 0.090 |
Why?
|
| Anopheles | 1 | 2009 | 9 | 0.090 |
Why?
|
| Drug Design | 1 | 2010 | 154 | 0.090 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2009 | 27 | 0.090 |
Why?
|
| Gene Targeting | 1 | 2009 | 39 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 106 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 143 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2004 | 1152 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 240 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2009 | 528 | 0.080 |
Why?
|
| Fascioliasis | 1 | 1986 | 18 | 0.070 |
Why?
|
| Antigens, Helminth | 1 | 1986 | 33 | 0.070 |
Why?
|
| Schistosomiasis | 2 | 1983 | 8 | 0.070 |
Why?
|
| Mitochondria | 1 | 2009 | 454 | 0.070 |
Why?
|
| Gene Amplification | 2 | 1999 | 24 | 0.070 |
Why?
|
| Humans | 6 | 2016 | 34853 | 0.060 |
Why?
|
| Paragonimus | 1 | 1983 | 1 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1149 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 160 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2004 | 834 | 0.050 |
Why?
|
| Primaquine | 1 | 2000 | 1 | 0.050 |
Why?
|
| Colombia | 1 | 2000 | 19 | 0.050 |
Why?
|
| Sulfadoxine | 1 | 2000 | 6 | 0.050 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2000 | 14 | 0.050 |
Why?
|
| Pyrimethamine | 1 | 2000 | 10 | 0.050 |
Why?
|
| Sentinel Surveillance | 1 | 2000 | 20 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2000 | 89 | 0.050 |
Why?
|
| DNA Primers | 1 | 2000 | 269 | 0.040 |
Why?
|
| Mutation | 2 | 2015 | 1023 | 0.040 |
Why?
|
| Karyotyping | 1 | 1999 | 46 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1986 | 445 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 310 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 555 | 0.040 |
Why?
|
| Urban Population | 1 | 2000 | 318 | 0.040 |
Why?
|
| Host-Parasite Interactions | 1 | 2015 | 43 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 93 | 0.030 |
Why?
|
| Immunodiffusion | 2 | 1986 | 4 | 0.030 |
Why?
|
| Prevalence | 1 | 2000 | 1425 | 0.030 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2014 | 2 | 0.030 |
Why?
|
| Lactams, Macrocyclic | 1 | 2014 | 7 | 0.030 |
Why?
|
| Solubility | 1 | 2014 | 115 | 0.030 |
Why?
|
| Rabbits | 2 | 1986 | 278 | 0.030 |
Why?
|
| Rats | 2 | 2011 | 3261 | 0.030 |
Why?
|
| Mice, Inbred CBA | 2 | 1983 | 32 | 0.030 |
Why?
|
| Atovaquone | 1 | 2011 | 1 | 0.030 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2011 | 14 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2000 | 2561 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 1530 | 0.020 |
Why?
|
| Plasmodium vivax | 1 | 2010 | 4 | 0.020 |
Why?
|
| Dogs | 1 | 2011 | 138 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 383 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2010 | 43 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 143 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 109 | 0.020 |
Why?
|
| Binding Sites | 1 | 2011 | 597 | 0.020 |
Why?
|
| Imidazoles | 1 | 2010 | 124 | 0.020 |
Why?
|
| Invertebrate Hormones | 1 | 1989 | 1 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2010 | 467 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 901 | 0.020 |
Why?
|
| Male | 2 | 2011 | 18870 | 0.020 |
Why?
|
| Chemical Fractionation | 1 | 1986 | 11 | 0.020 |
Why?
|
| Octoxynol | 1 | 1986 | 18 | 0.020 |
Why?
|
| Detergents | 1 | 1986 | 23 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1289 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1986 | 39 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 1986 | 80 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 1300 | 0.020 |
Why?
|
| Middle Aged | 1 | 1999 | 9642 | 0.020 |
Why?
|
| Immune Sera | 1 | 1983 | 59 | 0.010 |
Why?
|
| Immunization | 1 | 1983 | 90 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1982 | 83 | 0.010 |
Why?
|
| Immunity | 1 | 1982 | 51 | 0.010 |
Why?
|
| Antibodies | 1 | 1982 | 135 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1982 | 232 | 0.010 |
Why?
|
| Vaccination | 1 | 1982 | 259 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 67 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1989 | 84 | 0.010 |
Why?
|